sorbitol has been researched along with deferoxamine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Olsson, KS | 2 |
| Bobeck-Rutsaert, MM; Leijnse, B; op den Kelder, AM; van Eijk, HG; Wiltink, WF | 1 |
| Dekker, AW; Keunen, JE; Marx, JJ; Neijt, JP; Nortier, JW; Ros, FE; van Asbeck, BS; Voest, EE | 1 |
| Ganguly, NK; Gupta, R; Gupta, S; Joshi, K | 1 |
| Beer, SV; Oh, CS | 1 |
2 review(s) available for sorbitol and deferoxamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Molecular genetics of Erwinia amylovora involved in the development of fire blight.
Topics: Bacterial Proteins; Deferoxamine; Erwinia amylovora; Genomic Islands; Metalloproteases; Plant Diseases; Protein Transport; Rosaceae; Sorbitol; Virulence | 2005 |
2 trial(s) available for sorbitol and deferoxamine
| Article | Year |
|---|---|
Availability of iron sorbitol for hemoglobin formation as studied with phlebotomy.
Topics: Administration, Oral; Adult; Anemia, Hypochromic; Blood Volume; Bloodletting; Bone Marrow; Bone Marrow Cells; Clinical Trials as Topic; Deferoxamine; Drug Combinations; Hemoglobins; Hemosiderin; Humans; Injections, Intravenous; Iron; Male; Sorbitol; Time Factors | 1972 |
Phase I study using desferrioxamine and iron sorbitol citrate in an attempt to modulate the iron status of tumor cells to enhance doxorubicin activity.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Citrates; Citric Acid; Deferoxamine; Dose-Response Relationship, Drug; Doxorubicin; Drug Combinations; Drug Synergism; Eye; Female; Ferric Compounds; Humans; Iron; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms; Sorbitol; Tumor Cells, Cultured | 1993 |
4 other study(ies) available for sorbitol and deferoxamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Studies on iron stores built up by an iron-poly (sorbitol-gluconic acid) complex, Ferastral, in man. Preliminary report.
Topics: Bone Marrow; Deferoxamine; Drug Combinations; Gluconates; Humans; Iron; Liver; Reticulocytes; Sorbitol | 1977 |
Site of action of desferrioxamine in removing iron in normal and pathological conditions.
Topics: Anemia; Animals; Brain Chemistry; Deferoxamine; Heart; Infusions, Parenteral; Iron; Iron-Dextran Complex; Ketones; Kidney; Liver; Male; Muscles; Rats; Siderosis; Sorbitol; Spleen | 1974 |
Role of iron and iron chelation therapy in oxygen free radical mediated tissue injury in an ascending mouse model of chronic pyelonephritis.
Topics: Animals; Chelation Therapy; Chronic Disease; Citric Acid; Deferoxamine; Disease Models, Animal; Drug Combinations; Escherichia coli; Escherichia coli Infections; Female; Ferric Compounds; Free Radicals; Glucosephosphate Dehydrogenase; Glutathione Reductase; Histocytochemistry; Iron; Kidney; L-Lactate Dehydrogenase; Lipid Peroxides; Luminescent Measurements; Mice; Mice, Inbred BALB C; Pyelonephritis; Reactive Oxygen Species; Sorbitol | 1997 |